William T Hu
William T Hu
Associate professor, Rutgers Biomedical and Health Sciences
Verified email at
Cited by
Cited by
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease
S Salloway, R Sperling, NC Fox, K Blennow, W Klunk, M Raskind, ...
New England Journal of Medicine 370 (4), 322-333, 2014
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
MC Woodruff, RP Ramonell, DC Nguyen, KS Cashman, AS Saini, ...
Nature immunology 21 (12), 1506-1516, 2020
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
Z Zhang, M Song, X Liu, SS Kang, IS Kwon, DM Duong, NT Seyfried, ...
Nature medicine 20 (11), 1254-1262, 2014
The future of blood-based biomarkers for Alzheimer's disease
K Henriksen, SE O’Bryant, H Hampel, JQ Trojanowski, TJ Montine, ...
Alzheimer's & Dementia 10 (1), 115-131, 2014
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ...
Neurology 79 (9), 897-905, 2012
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
KA Josephs, JL Whitwell, DS Knopman, WT Hu, DA Stroh, M Baker, ...
Neurology 70 (19 Part 2), 1850-1857, 2008
Cognitive impairment and celiac disease
WT Hu, JA Murray, MC Greenaway, JE Parisi, KA Josephs
Archives of neurology 63 (10), 1440-1446, 2006
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases
JB Toledo, J Brettschneider, M Grossman, SE Arnold, WT Hu, SX Xie, ...
Acta neuropathologica 124, 23-35, 2012
Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment
WT Hu, A Chen-Plotkin, SE Arnold, M Grossman, CM Clark, LM Shaw, ...
Acta neuropathologica 119, 669-678, 2010
Distinct cerebral perfusion patterns in FTLD and AD
WT Hu, Z Wang, VMY Lee, JQ Trojanowski, JA Detre, M Grossman
Neurology 75 (10), 881-888, 2010
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis
TF Gendron, J Chew, JN Stankowski, LR Hayes, YJ Zhang, M Prudencio, ...
Science translational medicine 9 (383), eaai7866, 2017
Progressive aphasia secondary to Alzheimer disease vs FTLD pathology
KA Josephs, JL Whitwell, JR Duffy, WA Vanvoorst, EA Strand, WT Hu, ...
Neurology 70 (1), 25-34, 2008
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease
AS Chen‐Plotkin, WT Hu, A Siderowf, D Weintraub, R Goldmann Gross, ...
Annals of neurology 69 (4), 655-663, 2011
Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020
K Benameur, A Agarwal, SC Auld, MP Butters, AS Webster, T Ozturk, ...
Emerging infectious diseases 26 (9), 2016, 2020
Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ...
Neurology 85 (8), 692-700, 2015
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
T Chalermpalanupap, B Kinkead, WT Hu, MP Kummer, T Hammerschmidt, ...
Alzheimer's research & therapy 5, 1-9, 2013
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease
WT Hu, KA Josephs, DS Knopman, BF Boeve, DW Dickson, RC Petersen, ...
Acta neuropathologica 116, 215-220, 2008
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration
AS Chen-Plotkin, M Martinez-Lage, PMA Sleiman, W Hu, R Greene, ...
Archives of neurology 68 (4), 488-497, 2011
Alzheimer’s disease cerebrospinal fluid biomarker in cognitively normal subjects
JB Toledo, H Zetterberg, AC Van Harten, L Glodzik, P Martinez-Lage, ...
Brain 138 (9), 2701-2715, 2015
Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
JC Howell, KD Watts, MW Parker, J Wu, A Kollhoff, TS Wingo, CD Dorbin, ...
Alzheimer's research & therapy 9, 1-10, 2017
The system can't perform the operation now. Try again later.
Articles 1–20